Re:Mylan’s EpiPen price hike was a scheme to stifle competit...
by setum on Wednesday April 26, 2017 @10:09AM
(#14203073)
It's hardly a "free market" - the barrier to entry is very high due FDA approval process which can take decades and millions of dollars.
[ Parent
| on HN ]
There are no comments on this comment yet.